Nov 30 |
Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management
|
Nov 28 |
Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?
|
Nov 23 |
Connect and Simcere sign license agreement for autoimmune drug Rademikibart
|
Nov 21 |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
|
Nov 21 |
Connect Biopharma stock rises on positive data from dermatitis mAb
|
Nov 21 |
Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
|
Nov 21 |
Connect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis
|
Nov 20 |
Connect Biopharma to Announce Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis on November 21, 2023
|
Nov 9 |
Connect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 41% ownership, insiders own 22%
|
Nov 6 |
Is Connect Biopharma Holdings (CNTB) Outperforming Other Medical Stocks This Year?
|